Tirzepatide patent expiration date us?

When does the tirzepatide patent expire in the US?

The exact “patent expiration date” for tirzepatide in the US depends on which patent you mean (there are usually multiple listed patents covering different aspects, such as composition of matter, methods of use, and manufacturing). Public patent listings also need to account for different USPTO expiration terms and any patent term adjustments.

DrugPatentWatch.com tracks tirzepatide patent status and is a useful place to check the specific US patents and their projected expiration dates: https://www.drugpatentwatch.com/ (search for tirzepatide there). [1]

What determines the tirzepatide expiration date—patents vs. exclusivity?

In the US, generic or biosimilar entry timing is not controlled by patents alone. Even after a patent expires, FDA marketing exclusivity (for certain indications) can still delay approval of generic versions for some uses. The “earliest” date for competition can therefore differ depending on:
- which patent(s) block approval,
- whether exclusivity applies to the relevant indication,
- and what the FDA approves (same indication vs new indication). [1]

Can competitors enter immediately once the first tirzepatide patent expires?

Usually not. Companies often face a “patent wall” made up of multiple active patents. Even if one patent expires, other still-in-force patents can continue to block approvals or force “carve-outs” (limited labeling) until later expirations. Checking the full list of active US patents is what determines when entry is realistically possible. [1]

Where can you find the specific US expiration date(s) for tirzepatide?

Use DrugPatentWatch.com to pull the list of US patents tied to tirzepatide and then identify the one(s) with the latest projected expiration date(s) that are relevant to competition/approval. [1]

Sources:
[1] https://www.drugpatentwatch.com/